Dr. Thomas J. Fuchs is the Founder and Chief Scientist at Paige. He is a pioneer in the groundbreaking field of computational pathology whose inventions led to the first FDA-approved AI-based pathology product, Paige Prostate. Dr. Fuchs was named one of the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare in 2019. He is also the Dean of Artificial Intelligence and Human Health and Co-Director of the Hasso Plattner Institute for Digital Health at the Icahn School of Medicine at Mount Sinai.

Previously, he was Associate Professor for Machine Learning at Weill-Cornell University, Director of the Warren Alpert Center for Digital and Computational Pathology at Memorial Sloan Kettering Cancer Center and Research Technologist at NASA’s Jet Propulsion Laboratory. Dr. Fuchs holds a Doctor of Sciences from ETH Zurich in Machine Learning and a MS in Technical Mathematics from Graz Technical University in Austria.

Ashita Batavia, MD MSc is a Senior Director of Advanced Analytics in Research & Development (R&D) at Janssen Pharmaceuticals. Previously, Ashita was a leader in Evidence Generation using Real World Data at McKinsey & Co. and, earlier in her career, was a co-Investigator on a multi-year NIH-funded HIV clinical trial. She has received numerous prestigious academic research grants and awards, has multiple peer-reviewed publications and is currently a Clinical Assistant Professor of Medicine at Weill Cornell Medicine.

Ashita has a Master of Epidemiology degree, and is Board Certified in both Internal Medicine and Infectious Diseases. She is also currently an Attending Physician at NY Presbyterian Hospital and has served on the frontline throughout the COVID-19 pandemic. She lives in Westchester, N.Y. with her husband and two children.

Julia Bernstein is the Head of Operations and Strategy at Thirty Madison. She’s responsible for the functions that power Thirty Madison's care models, including customer experience, medical operations, and pharmacy, as well as driving corporate strategy and shaping our position in the evolving digital health landscape. Julia knows the healthcare system inside and out. Before Thirty Madison, Julia held leadership roles in the behavioral health space at Tempest (now Monument), Beacon Health Options (now part of Elevance) and Ginger (now Headspace Health). She brings her strategic and healthcare industry expertise, and a constant focus on patients to helping Thirty Madison become the premier healthcare company for people living with chronic conditions

Julia received her AB summa cum laude from Dartmouth College and her MBA from the Stanford Graduate School of Business. She lives in New York with her husband and two children.

As Happify Health’s Chief Strategy Officer, Chris is leading the effort to bring Happify’s Intelligent Health platform to the pharmaceutical and healthcare industry. Recently he served as a Board Member of the Digital Therapeutic Alliance (DTA). In addition, he was a professor at the University of Utah and served as Executive Director of the Sorenson Center for Discovery & Innovation, a digital therapeutic game incubator. He is the co-author of two books on innovation, creativity, and leadership: Tension - The Energy of Innovation; and Solving for Why - Change Your Identity, Change Your Future.

He is the named inventor on 12 issued patents, has been a founding leader in 10 startups, and has held leadership positions at JP Morgan and PwC. He holds a doctorate from George Washington University in Human and Organizational Learning, and an M.B.A. from UCLA Anderson School.

Jon Gordon is Co-Founder and Managing General Partner of HC9 Ventures, a venture fund that provides deep healthcare expertise to emerging healthcare companies through an engaged LP network of leading healthcare executives and entrepreneurs. Jon previously served as Senior Vice President for Innovation at Commonwealth Care Alliance, a non-profit health plan focused on caring for vulnerable populations, and Managing Director of Winter Street Ventures, their corporate venture arm. He simultaneously was interim CEO of the Winter Street portfolio LifePod, a proactive voice-based remote patient monitoring and engagement digital health company.

Previously, Jon founded NYP Ventures, the strategic venture capital arm of NewYork-Presbyterian. In that role, Jon led investments in eleven digital health businesses, built strategic partnerships with leading national healthcare companies, and managed the hospital's intellectual property portfolio. Jon also co-founded the Strategic Venture Group, a collaborative network of more than twenty health system-based venture funds. Jon was also a Director in NYP's Office of Strategy, where he worked on projects ranging from launching the hospital's Medicare accountable care organization to building a telehealth program. Before joining NYP, Jon was co-founder, President & COO of EveryDay Medical, an e-commerce-based provider of durable medical equipment.

Jon is an adjunct faculty member at the Columbia Mailman School of Public Health and serves as a board member of Costs of Care and Woodstock Day School. Jon is an avid cyclist and hiker, having completed challenges such as the Race Across America, the WOW Cyclothon around Iceland, and the Catskill 3500 High Peaks. He holds a BA cum laude from Princeton University and an MBA with honors from Columbia Business School.

Dr. Jeff Wessler is a Virtual Cardiologist and the Founder and CEO of Heartbeat Health. Heartbeat Health delivers virtual cardiology via remote diagnostics, telemedicine, and management for cardiac patients with atrial fibrillation, vascular disease, and heart failure.

Dr. Wessler graduated from Williams College, received an MPhil in public health and epidemiology from Cambridge University, and his MD from Harvard Medical School. He completed a cardiology fellowship at New York Presbyterian-Columbia, being named Chief Resident of the medicine program. He is currently an assistant professor of medicine at Northwell Health. Dr. Wessler is a father, an avid squash player, and was raised in Boston.